Lexology January 17, 2025
McDermott Will & Emery

On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for Telemedicine and Limited State Telemedicine Registrations. This proposed rule would establish three special registrations, creating pathways for telehealth practitioners to prescribe, and online platforms to dispense, certain controlled substances via telemedicine after flexibilities expire on December 31, 2025. However, it is unclear whether the incoming Trump administration will move forward with the proposed approach for special registration.

In Depth

WHY IT MATTERS

  • Current federal telehealth-focused controlled substance prescribing flexibilities, initially invoked in response to the COVID-19 public health emergency (PHE), will expire December 31, 2025.
  • Absent the flexibilities, current law would require telemedicine providers to perform an in-person medical evaluation of...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Govt Agencies, Provider, Technology, Telehealth
Another Reprieve? Proposed Budget Bill Includes Telehealth, HaH Extensions
House expected to consider CR to fund government through Sept. 30, extend key health care provisions
3 million Americans live where even telehealth can't reach: 6 notes
DEA role must be clearly defined in controlled substance Rx via telemedicine, expert cautions
Teledermatology Benefits Underserved Populations, Reduces Physician Burnout

Share This Article